Previous 10 | Next 10 |
home / stock / cphrf / cphrf news
2024-01-08 00:03:36 ET Summary Assertio Holdings has dropped substantially and is down more than 70% in the past year. Assertio Holdings appears to have been oversold based on quantitative factors. It trades at a very low enterprise value to revenue ratio compared to its peers. ...
2023-11-10 10:37:09 ET Cipher Pharmaceuticals Inc. (CPHRF) Q3 2023 Earnings Conference Call November 10, 2023, 08:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Bryan Jacobs - Chief Financial Officer Conference Call Participants ...
2023-11-09 18:17:59 ET Cipher Pharmaceuticals press release ( OTCPK:CPHRF ): Q3 GAAP EPS of $0.27. Revenue of $6.1M (+27.1% Y/Y). For further details see: Cipher Pharmaceuticals GAAP EPS of $0.27, revenue of $6.1M
2023-08-11 12:25:02 ET Start Time: 08:30 End Time: 09:00 Cipher Pharmaceuticals Inc. (CPHRF) Q2 2023 Earnings Conference Call August 11, 2023, 08:30 AM ET Company Participants Craig Mull - Interim CEO Bryan Jacobs - CFO Conference Call Participants ...
2023-08-11 10:37:17 ET Cipher Pharmaceuticals press release ( OTCPK:CPHRF ): Q2 GAAP EPS of $0.12. Revenue of $5.3M (-5.4% Y/Y). For further details see: Cipher Pharmaceuticals GAAP EPS of $0.12, revenue of $5.3M
2023-05-12 12:33:05 ET Cipher Pharmaceuticals Inc. (CPHRF) Q1 2023 Earnings Conference Call May 12, 2023 8:30 am ET Corporate Participants Craig Mull - Interim Chief Executive Officer Bryan Jacobs - Chief Financial Officer Conference Call Participants Dou...
2023-05-11 17:53:13 ET Cipher Pharmaceuticals press release ( OTCPK:CPHRF ): Q1 GAAP EPS of $0.10 beats by $0.02 . Revenue of $4.9M (-9.3% Y/Y) misses by $0.64M . For further details see: Cipher Pharmaceuticals GAAP EPS of $0.10 beats by $0.02, revenue of $4....
2023-03-17 11:48:04 ET Cipher Pharmaceuticals Inc. (CPHRF) Q4 2022 Earnings Conference Call March 17, 2023 08:30 ET Company Participants Craig Mull - Interim Chief Executive Officer Bryan Jacobs - Chief Financial Officer Conference Call Participants Doug ...
Cipher Pharmaceuticals Inc. (CPHRF) Q3 2022 Earnings Conference Call November 11, 2022 08:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Bryan Jacobs - Chief Financial Officer David Miller - Director, Finance Conference Call Part...
Cipher Pharmaceuticals press release ( OTCPK:CPHRF ): Q3 GAAP EPS of $0.11. Revenue of $4.8M (+6.7% Y/Y). For further details see: Cipher Pharmaceuticals GAAP EPS of $0.11, revenue of $4.8M
News, Short Squeeze, Breakout and More Instantly...
Companhia Siderurgica Paulista Nova Cosipa Company Name:
CPHRF Stock Symbol:
OTCMKTS Market:
Cipher Pharmaceuticals Reports First Quarter 2024 Results Canada NewsWire (All figures are presented in U.S. Dollars) Adjusted EBITDA in Q1 2024 was $3.6 million , an increase of 12.5% over Q1 2023 Epuris sales volumes grew 7.2% in the quarter over Q1 2023, c...
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , May 3, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release ...
Mississauga, Ontario--(Newsfile Corp. - April 3, 2024) - Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre . CEO Cr...